Andrew Roddam BSc, DPhil

Andrew is currently Vice President and head of Epidemiology, RWE and Digital Clinical Platforms at GSK, and is a renowned expert in epidemiological research with specific interest in the utilisation of routine data for research purposes. Andrew obtained his DPhil in Statistics at the University of Oxford and completed a post-doc in Infectious Disease Epidemiology. He was a Senior Researcher at the CRUK Cancer Epidemiology Unit at the University of Oxford before taking up an appointment at Amgen where he was most recently Regional Head (EU, EEMEA) in the Center for Observational Research. In his current role,he oversees the teams responsible for the epidemiological input into the discovery and development of new medicines as well as the real-world data and analytics group and the team charged with delivering innovation in real-world study execution. Andrew is a participant on several expert groups and advisory committees both in the UK and internationally where his expertise in epidemiological methods and health informatics are highly regarded.